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Dissecting the structural basis of 
MEIG1 interaction with PACRG
Wei Li1,*, Ninad M. Walavalkar2,*, William A. Buchwald2, Maria E. Teves1, Ling Zhang1,3, 
Hong Liu1,3, Stephanie Bilinovich2, Darrell L. Peterson4, Jerome F. Strauss III1,4, 
David C. Williams Jr2 & Zhibing Zhang1,4
The product of the meiosis-expressed gene 1 (MEIG1) is found in the cell bodies of spermatocytes 
and recruited to the manchette, a structure unique to elongating spermatids, by Parkin co-regulated 
gene (PACRG). This complex is essential for targeting cargo to the manchette during sperm flagellum 
assembly. Here we show that MEIG1 adopts a unique fold that provides a large surface for interacting 
with other proteins. We mutated 12 exposed and conserved amino acids and show that four of these 
mutations (W50A, K57E, F66A, Y68A) dramatically reduce binding to PACRG. These four amino acids 
form a contiguous hydrophobic patch on one end of the protein. Furthermore, each of these four 
mutations diminishes the ability of MEIG1 to stabilize PACRG when expressed in bacteria. Together 
these studies establish the unique structure and key interaction surface of MEIG1 and provide a 
framework to explore how MEIG1 recruits proteins to build the sperm tail.
Mouse meiosis expressed gene 1 (Meig1) was originally identified during a search for mammalian genes poten-
tially involved in meiotic processes1–3, and subsequent studies suggested that MEIG1 might play roles in meiosis 
in both male and female germ cells4–7. However, studies from two independent laboratories highlighted its role in 
spermiogenesis, the final phase of spermatogenesis in which elongating/condensing spermatids form a flagellum 
and differentiate into sperm. We discovered that Meig1 mutant male mice are all infertile due to severe defects 
in spermiogenesis8. The homozygous mutant females were fertile. When the floxed Meig1 mice were crossed to 
cell-type specific Cre transgenic mice, we discovered that MEIG1′ s primary role is in germ cells9. The male infer-
tility and spermatogenesis defects in MEIG1-deficient mice were independently replicated using another mutant 
mouse generated by another laboratory10.
MEIG1′ s function in spermiogenesis has been further studied in our laboratory. Using yeast two-hybrid screen, 
we found that Parkin co-regulated gene (PACRG) to be a major binding partner8. Mice lacking MEIG1 and PACRG 
share an identical reproductive phenotype of male infertility due to a defect in spermiogenesis11–13. Our recent 
studies demonstrated that PACRG protein is expressed at approximately day 30 after birth during the first wave 
of spermatogenesis, when the germ cells differentiate into elongating spermatids. The protein is localized in the 
manchette, a structure unique to male germ cells, which is only present in the elongating spermatids where it is 
thought to transport cargos and direct formation of the sperm flagellum14,15. MEIG1 protein is expressed much 
earlier than PACRG. It is localized in the whole cell body of spermatocytes and round spermatids, but migrates 
to the manchette when germ cells develop into elongating spermatids. This targeting process is dependent on 
PACRG16. Thus, MEIG1 and PACRG form a complex in the manchette and which is believed to transport cargo 
for construction of the sperm tail.
One of the cargos needed to construct the sperm tail axoneme is SPAG16L. The mammalian Spag16 gene is the 
orthologue of Chlamydomonas reinhardtii Pf20, which is essential for flagellar motility8–10. Using the C-terminus 
of SPAG16L protein as bait, a yeast two-hybrid screen identified MEIG1 as a binding partner10. In MEIG1 and 
PACRG-deficient mice, SPAG16L fails to localize to the manchette, consistent with the notion that the MEIG1/
PACRG complex is involved in transporting and targeting sperm tail components to the site of flagellum assembly.
The mouse Meig1 gene yields multiple transcripts expressed in both germ cells and somatic cells in the testis, 
but all these transcripts translate into the same protein3,8. MEIG1 is a small protein, with only 88 amino acids, 
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and no known functional domains have been identified by bioinformatics analyses. How does this small protein 
associate with different proteins, such as PACRG and SPAG16L? To answer this question, we took advantage of 
nuclear magnetic resonance (NMR) to resolve the MEIG1 structure. We discovered that MEIG1 adopts a unique 
fold that provides a large contact surface for binding to other proteins. The shape of MEIG1 resembles a dumb-
bell, such that associated proteins can bind either of two opposing concave surfaces or the two convex ends of the 
dumbbell. Based on this structure we mutated 12 solvent exposed amino acids in MEIG1 protein that may mediate 
interaction with other proteins. Four amino acids, W50, K57, F66, and Y68, which are on the same large globular 
domain, significantly affect binding to PACRG. In addition, PACRG is not stable in bacteria, but could be stabi-
lized by wild-type MEIG1. The ability to stabilize PACRG was also reduced in the four mutant MEIG1 proteins. 
Finally, a double mutation (W50A/Y68A) further reduced the binding strength and ability to stabilize PACRG as 
compared to the single mutations alone. These studies established the structure of MEIG1, and the amino acids 
that mediate interactions with PACRG. They provide a basis for exploring the structural mechanisms of MEIG1 
interaction with other proteins involved in formation of the sperm tail.
Results and Discussion
Mouse MEIG1 adopts a unique fold with a large solvent exposed surface area. The MEIG1 pro-
tein is well-behaved in isolation and remains a monomer at high concentration based on both the elution profile 
from size exclusion chromatography as well as the narrow linewidths observed in the 2D 15N-HSQC spectrum 
(Fig. 1). The solution structure of MEIG1 reveals a unique fold that provides a large surface area for binding to 
other proteins. The structure was well determined experimentally (Table 1) with an RMSD of 0.4 Å for backbone 
and 1.0 Å for all heavy atoms of ordered residues (amino acids 8–88). An overlay of the twenty lowest energy struc-
tures (Fig. 2A) shows a very tight ensemble of structures with only small variations in the backbone. The protein 
adopts a very unique fold without any close structural homologues identified by either VAST or DALI searches17,18. 
The first alpha helix (α 1) functions as a central axial hub. Two additional helices (α 2, α 3) and a small beta sheet 
(β 1/β 4) and a beta hairpin (β 2/β 3) pack circumferentially around α 1. This organization leads to an irregular disc 
shaped structure that appears as a lopsided dumbbell when viewed on edge (Fig. 2A,B). The smaller end of the 
dumbbell collapses around a core formed largely by branch chained hydrophobic residues while the larger end of 
the dumbbell collapses around a core of aromatic side chains. In this manner, the hydrophobic core of the pro-
tein is distributed concentrically around the central α -helix. Previous studies have suggested MEIG1 can form a 
homodimer through intermolecular disulfide bond formation5. However, the single cysteine residue in MEIG1 is 
completely buried with a solvent exposed surface area of less than 1%. Therefore, the conformation of the protein 
precludes intermolecular disulfide bond formation in the absence of large structural rearrangements or unfolding.
Given this unique fold, we investigated whether evolutionary conservation is consistent with the formation of 
a relatively distributed hydrophobic core. Sequence conservation analysis was performed with the online ConSurf 
Server (http://consurf.tau.ac.il/)19,20 which identifies homologous proteins, performs a multiple sequence alignment, 
and calculates position specific conservation scores using an empirical Bayesian algorithm. The results are shown 
in Fig. 2C in which each residue of MEIG1 is colored according to conservation score. The central helix and core 
residues show the highest conservation while solvent exposed and disordered residues show the least. The second 
α -helix and subsequent loop region shows the lowest conservation for the structured portion of the protein. This 
pattern of conservation is consistent with the central helix forming the central core of the protein structure.
The overall fold and dumbbell shape of the protein provides a fairly large surface area for binding to other pro-
teins. The solvent accessible surface area for the structured domain (amino acids 8–88) is 6014.5 Å2 (as calculated 
by VMD21, solvent radius = 1.4 Å), whereas the expected solvent accessible surface area for a globular domain 
comprised of 81 amino acids is 5684.6 Å2,22, for a difference of 320 Å2. The surface charge calculated by the APBS 
program23–25 shows distinct patches of positive and negative charges on opposing surfaces of the protein (Fig. 2D). 
In addition, three aromatic residues, Phe66, Tyr68, Trp50, as well as the positively charged Lys57 are well conserved 
Figure 1. MEIG1 is monomeric in isolation. (A) MEIG1 protein elutes as a single peak on a Superdex 75 
26/60 gel filtration column (GE Healthcare) at a volume of 233 mL, consistent with a monomer (apparent 
molecular weight of ~9 kDa as compared to the expected molecular weight of 11 kDa). SDS-PAGE analysis 
shows that the protein migrates as a single band at an appropriate molecular weight. (B) A 2D 15N-HSQC 
spectrum of MEIG1 shows sharp and well dispersed resonances consistent with a stable folded monomer.
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and exposed on the large end of the dumbbell (Fig. 2C). Therefore MEIG1 presents a fairly large surface area such 
that associated proteins can bind charged or hydrophobic patches on either of two opposing concave surfaces or 
the two convex ends of the dumbbell (Fig. 2E). Hence the structure of MEIG1 is consistent with the role of the 
protein as an adaptor that recruits cargo to the manchette for delivery out the sperm tail.
A solvent exposed hydrophobic patch is critical for binding PACRG. In previous studies, we have 
shown that MEIG1 forms a complex with PACRG within the manchette of spermatids and is necessary for the 
delivery of cargo and formation of the sperm tail26. Based on the solution structure, 12 solvent exposed, hydro-
phobic or charged residues were identified as potential mediators of protein-protein interactions. These 12 amino 
acids were mutated as described in supplemental Table 1, and binding strength between PACRG with wild-type 
and mutated MEIG1 proteins was tested by direct yeast two hybrid experiments.
The mutations were introduced using MEIG1/pGBKT7 as template. To test if the mutations affect MEIG1 
protein expression, the wild-type and all the mutated plasmids were transformed into yeast strain AH109, and 
yeast lysates were prepared for Western blot analysis using an anti-MEIG1 antibody. There was no difference in 
MEIG1 expression level among all the mutants (Supplemental Fig. 1). The wild-type and mutated plasmids were 
co-transformed into AH109 together with PACRG/pGADT7, and an empty pGADT7 was also co-transformed as 
negative controls, and selection medium was used for yeast growth. All the yeast grew when the yeast expressed 
both PACRG and MEIG1, either wild-type or mutated. However, no yeast grew when empty vector was used 
(Supplemental Fig. 2). The results indicate that PACRG still interacts with MEIG1 even if it is mutated.
NMR distance and dihedral constraints
Distance constraints
 Total NOE 1234
 Intra-residue 368
 Inter-residue
  Sequential (|i – j| = 1) 323
  Medium-range (|i – j| ≤ 4) 187
  Long-range (|i – j| > 5) 356
 Hydrogen bonds 38
Total dihedral angle restraints 172
 φ 78
 ψ 76
 χ 1 18
Total RDCs
 NH 60
 NC’ 44
Q%
 NH 1.8
 NC’ 32.1
Structure statistics
Violations (mean and s.d.)
 Distance constraints (Å) 0.002 ± 0.001
 Dihedral angle constraints (°) 0.9 ± 0.4
 Max. dihedral angle violation (°) 6.8
 Max. distance constraint violation (Å) 0.07
Deviations from idealized geometry
 Bond lengths (Å) 0.0031 ± 0.0002
 Bond angles (°) 0.45 ± 0.03
 Impropers (°) 0.40 ± 0.03
Average pairwise r.m.s. deviation** (Å) 
 Heavy 1.0 ± 0.1
 Backbone 0.4 ± 0.1
Ramachandran plot summary
Most favored regions 90.5%
Additionally allowed regions 9.4%
Generously allowed regions 0.1%
Disallowed regions 0.1%
Table 1.  NMR and refinement statistics. **Pairwise r.m.s. deviation from the mean was calculated among 20 
lowest energy refined structures for ordered residues.
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Figure 2. Solution structure of MEIG1. The structure of MEIG1 was determined by NMR spectroscopy.  
(A) An overlay of the 20 lowest energy structures (ordered residues 8–88) shows that MEIG1 adopts a unique 
fold. Two α -helices (α 2, α 3 – shown in red) and two small β -sheets (β 1/β 4, β 2/β 3 – shown in blue) surround a 
central alpha helix (α 1) to form relatively flat dumbbell shaped molecule. (B) A clustal omega alignment42 of the 
mouse (Mm), human (Hs), chicken (Gg) MEIG1 primary sequence is shown with secondary structure elements 
(blue arrow – sheet, red oval – helix) indicated above the sequence. (C) A schematic diagram shows that the 
overall shape of MEIG1 (yellow) provides four potential binding surfaces to interact with associated proteins 
(grey). (D) A ribbon diagram depicting MEIG1 in two different orientations (rotated by 180°) is colored based 
on conservation score as determined by ConSurf20. The colors range from turquoise (most variable) to maroon 
(most conserved). The 12 amino acids identified for mutagenesis are depicted as sticks and labeled. (E) The 
solvent accessible surface of MEIG1in two different orientations (rotated by 180°) is colored according to 
electrostatic charge as determined by APBS and PDB2PQR23–25.
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Binding strength between PACRG with wild-type MEIG1 and the mutated MEIG1 proteins was evaluated 
by measuring α -galactosidase activity. Of the 12 mutations, four (W50A, K57E, and F66A, particularly Y68A) 
significantly reduced binding (Fig. 3A). These four amino acids are solvent exposed on the convex surface of the 
large end of the dumbbell (Fig. 3B). These results indicate that this exposed hydrophobic patch forms the interac-
tion interface with PACRG. To confirm that we have not disrupted the global fold of the protein, the MEIG1Y68A 
mutant was isotopically labeled and a 2D 15N-HSQC compared with that of wild-type protein. As can be seen in 
Supplemental Fig. 3A,B, mutating this residue leads to relatively minor chemical shift changes for only a few res-
onances in the vicinity of Y68. The 2D spectrum otherwise remains quite dispersed and very similar to wild-type 
protein. Since chemical shifts are highly sensitive to changes in local environment, these findings confirm that 
MEIG1Y68A maintains a native fold. In addition, each of the mutant proteins that affect binding to PACRG was 
analyzed by size exclusion chromatography (Supplemental Fig. 3C).The elution profiles were similar to wild type 
protein and appropriate for a monomeric globular domain. This study further confirms that these mutations do 
not unfold the protein or lead to large structural changes.
We further compared binding strength between PACRG with MEIG1 carrying single mutations (W50A and 
Y68A) and W50A/Y68A double mutations, and discovered that yeast co-transformed with PACRG and MEIG1 
with W50A/Y68A double mutations still grew on the selection plate (Supplemental Fig. 4), however, the binding 
strength was significantly reduced in the double mutations (Fig. 3C).
Figure 3. Binding strength between PACRG with wild-type and mutant MEIG1. Yeast strain AH109 were 
co-transformed with indicated plasmids, and binding strength was analyzed by measuring α -galactosidase 
activity. (A) Binding strength between PACRG with wild-type MEIG1 and individual MEIG1 mutants. Notice 
that compared to the binding strength between PACRG with wild-type MEIG1, the binding strengths in 
W50A, K57E, F66A, particularly Y68A, were significantly reduced. *p < 0.05. (B) Residues involved in binding 
to PACRG. The four residues critical for binding PACRG (W50, K57, F66, and Y68) are shown as yellow 
spheres on a blue ribbon diagram. These four residues form a contiguous surface on the large globular end of 
the protein. (C) Binding strength in double mutations. Notice that binding strength in W50A/Y68A double 
mutations is significantly lower than single W50A or Y68A mutation. The binding strength between PACRG 
and wild-type MEIG1 is even higher than the positive P53 and large T antigen. *p < 0.05 compared to wild type, 
and #p < 0.05 compared to Y68A mutation.
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Human PACRG is degraded, in part, by the ubiquitin-proteasome system27,28. Mouse PACRG expression was 
significantly increased by the proteasome inhibitor MG132 in transfected COS-1 cells, indicating that mouse 
PACRG is also regulated, in part, destroyed by the same mechanism26. As in cultured mammalian cells, mouse 
PACRG protein is not stable in bacteria. However, in transfected mammalian cells, PACRG protein is easily detected 
by the Pico system (Pierce) in Western blot analysis, but not in bacteria. The His-tag labeled PACRG protein from 
bacteria transformed with PACRG/pET28A plasmid was not visualized by Coomassie blue staining after IPTG 
induction. After standard His-tag protein purification procedure, no PACRG protein was visualized by either 
Coomassie blue staining or Western blot using the Pico (Pierce) system. However, a small amount of PACRG pro-
tein was indeed expressed, because it was detectable when a higher sensitivity Femto system (Pierce) was used for 
Western blot analysis (Supplemental Fig. 5). We concluded that in bacteria, PACRG protein is degraded quickly, 
and is not as stable as in the mammalian cells.
In cultured mammalian cells, the PACRG expression level was increased by co-expressing MEIG1, suggesting 
that PACRG is stabilized by MEIG126. We next decided to co-express MEIG1 and PACRG in bacteria and deter-
mine if MEIG1 also protects PACRG in the prokaryotic system. Full-length mouse Pacrg cDNA was cloned into 
the upstream multiple clone site of the dual expression vector pCDFDuet-1 to create the PACRG/pCDFDuet-1 
plasmid, and the translated protein was tagged with hexahistidine. The full-length mouse Meig1 cDNA was inserted 
into the downstream multiple cloning site to create PACRG/MEIG1/pCDFDuet-1 plasmid. Similar to what was 
observed with the PACRG/pET28A expression vector, no PACRG protein was detectable when the less sensitive 
Pico system was used for Western blot analysis if the bacteria were transformed with PACRG/pCDFDuet-1 plasmid 
and induced by IPTG, but the PACRG protein was detectable when the high sensitive Femto system was used for 
Western blot analysis. However, when the bacteria were transformed by PACRG/MEIG1/pCDFDuet-1 plasmid, 
the PACRG was easily detectable with the Pico system (Fig. 4A), even though the protein was still not visualized 
by Coomassie blue staining. This suggests that wild-type MEIG1 also stabilizes PACRG in bacteria. Association 
between PACRG and MEIG1 in bacteria was further supported by the fact that the two proteins eluted in the 
same fractions when gel filtration experiments were conducted using the bacteria lysates. Expressing both PACRG 
(with His tag) and MEIG1 in bacteria yielded a small amount of soluble protein purified by Ni and gel filtration 
chromatography. The eluted protein was concentrated and passed over the gel filtration column a second time. 
Western blot analysis of the eluted protein confirms that both MEIG1 and PACRG were co-purified which confirms 
formation of a stable complex (Fig. 4B).
Using these systems, we tested whether the four mutants disrupted the ability of MEIG1 to stabilize PACRG in 
bacteria. We co-expressed the four mutant MEIG1 proteins with PACRG as described previously. Both Coomassie 
blue staining and Western blot analysis using the bacteria lysates showed that MEIG1 expression levels were not 
changed when the amino acids were mutated (Fig. 5A and Supplemental Figure 6A). However, compared to the 
wild-type MEIG1, PACRG expression levels were dramatically reduced in the four MEIG1 mutants, particularly for 
the Y68A mutation (Fig. 5A) which also showed the lowest the binding strength. We further examined the affect of 
the W50A/Y68A double mutation on stabilization of PACRG. Like in the single mutations, this double mutation 
did not change MEIG1 expression level as indicated by both Coomassie blue staining and Western blot analysis 
(Fig. 5B and Supplemental Figure 6B). Compared to W50A and Y68A single mutations, the PACRG expression 
level was even lower when co-expressed with the W50A/Y68A MEIG1 double mutation (Fig. 5B).
Figure 4. Association between MEIG1 and PACRG in bacteria. (A) MEIG1 stabilizes PACRG in bacteria. 
Notice that PACRG was only detectable by the high sensitivity Femto system in Western blot analysis when the 
bacteria were transformed with PACRG/pCDFDuet-1 plasmid; However, when the bacteria were transformed 
with PACRG/MEIG1/pCDFDuet-1 plasmid to express MEIG1 protein, PACRG was detectable by less sensitive 
Pico system. (B) PACRG and MEIG1 were co-purified in gel filtration experiments. Lysates from bacteria 
expressing both PACRG and MEIG1 were filtrated and Western blotting was conducted. PACRG and MEIG1 
were present in the same fractions.
www.nature.com/scientificreports/
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Hence, the four mutations we identified not only reduce binding strength but also reduce the ability of MEIG1 
to stabilize PACRG in bacteria. In addition, the W50A/Y68A double mutation reduces binding strength and the 
ability to stabilize PACRG to a greater extent than either single mutation alone. Together, these studies establish 
the structure of MEIG1 and the amino acids that mediate interactions with PACRG, and open the possibility of 
exploring the structural mechanism for MEIG1 interaction with other proteins.
Methods
MEIG1 Protein expression and purification. We previously constructed the full-length mouse MEIG1/
pET28A plasmid with hexahistidine tags in both N and C-termini of MEIG1 protein8. A stop codon was inserted 
after the coding region, creating the construct with only the N-terminal hexahistidine tag and intervening throm-
bin cleavage site. Uniform 15N, 13C labeled protein was expressed by growth in labeled M9 media29 and induction 
with 1 mM isopropyl β -D-1-thiogalactopyranoside (IPTG) at 37 °C for 4 hours. For the majority of NMR samples 
(including assignment and NOE data), bacteria were lysed with B-PER™ Bacterial Protein Extraction Reagent 
(Thermo Scientific) and the soluble fraction purified over a nickel column. To improve the yield of protein for 
residual dipolar coupling measurements, the bacteria were lysed in 6 M guanidine hydrochloride, 20 mM Tris pH 
8.0, and the protein refolded by dialysis against 20 M Tris pH 8.0, 150 mM NaCl, 2 mM β -mercaptoethanol. The 
refolded protein was purified over a nickel column, the thioredoxin and hexahistidine tags removed by thrombin 
cleavage, and the protein isolated by gel filtration and ion exchange chromatography. The refolded protein shows 
nearly identical elution profile and NMR spectra as compared to protein purified under native conditions.
NMR spectroscopy. Purified protein was buffer exchanged into 10 mM NaPO4, pH 6.5, 1 mM dithiothreitol, 
10% 2H2O, and 0.02% sodium azide and concentrated to 0.5–1.0 mM. Standard triple resonance NMR spectra 
for resonance assignments, distance restraints, residual dipolar couplings, and torsion angle restraints (three 
dimensional HNCO, HNCACB, CCH-TOCSY, HBHA(CBCACO)NH, H(CCO)NH, C(CCO)NH,13C-NOESY, 
15N-NOESY, IPAP-HNCO experiments and two dimensional IPAP-HSQC and quantitative J correlation spectros-
copy experiments)30–32 were collected on Bruker Avance 700 MHz and 850 MHz instruments. Data were processed 
with NMRPipe33 and analyzed with CcpNmr34,35. Residual dipolar couplings were measured for a partially aligned 
sample in 5% PEG:hexanol (C12E5; r = 0.85)36.
Structure calculation. Backbone torsion angle restraints were derived from chemical shift index using the 
TALOS-N software37. Hydrogen bond distance and angular restraints were introduced based on TALOS-N pre-
dictions and characteristic NOE patterns. The initial structure was calculated with automatic NOE assignments 
based on NOE, hydrogen bond, and torsion angle restraints using the CYANA program38,39. The final structure was 
Figure 5. MEIG1 stabilizes PACRG in bacteria, but the ability was reduced when mutated. (A) The ability 
to stabilize PACRG is reduced in the four MEIG1 mutations. Upper panel shows a representative Western blot 
result from bacteria lysates. Notice that PACRG expression levels were reduced when bacteria expressed the 
four mutated MEIG1 proteins. Lower panel shows the relative PACRG expression levels normalized by MEIG1 
protein expression levels in the four mutants compared to the wild-type MEIG1 protein. *p < 0.05 compared to 
wild type. (B) Double MEIG1 mutations cause a greater reduction in PACRG expression. Upper panel shows a 
representative Western blot result with indicated single and double mutations. Lower panel shows the relative 
PACRG expression levels normalized by MEIG1 protein expression levels. Notice that in the double mutations, 
PACRG level is lower than the single mutation alone. *p < 0.05 compared to wild type, and #p < 0.05 compared 
to Y68A mutation.
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refined based on NOE distance, hydrogen bond distance and angle, torsion angle, and residual dipolar coupling 
restraints as well as a torsion angle database potential of mean force40 using the Xplor-NIH software package41.
Other plasmid constructs. MEIG1/pGBKT7 was constructed previously8. Full-length mouse Pacrg cod-
ing region was amplified by PCR and cloned into pGADT7 vector to create PACRG/pGADT7 plasmid. Mouse 
full-length Pacrg cDNA was also cloned into pET28A or pCDFDuet-1 vectors in order to express PACRG in 
bacteria. Based on the PACRG/pCDFDuet-1 plasmid, full-length mouse Meig1 cDNA was inserted into the sec-
ond multiple cloning site of the pCDFDuet-1 vector to create PACRG-MEIG1-pCDFDuet-1 plasmid. All related 
primers are listed in the supplemental table.
Site-directed mutagenesis. The MEIG1/pGBKT7, PACRG-MEIG1-pCDFDuet-1 or MEIG1/pET28A plas-
mids were used as templates, and the indicated amino acids of MEIG1 protein were mutated using a QuikChange 
XL Site-directed Mutagenesis kit (Agilent Technologies, Santa Clara, CA) and the mutations were confirmed by 
DNA sequencing. All related primers are listed in the supplemental table.
Direct yeast two-hybrid experiment. To detect interaction between wild-type mouse PACRG protein 
and wild-type mouse MEIG1 or mutant MEIG1 proteins, PACRG/pGADT7 and wild-type or mutant MEIG1/
pGBKT7 were co-transformed into the AH109 host strain using the Match-Maker two-hybrid System 3 (Clontech). 
Expression of both proteins (PACRG and MEIG1) was analyzed by Western blot. The AH109 transformants 
harboring both MEIG1/pGBKT7 (wild-type or mutant) and PACRG/pGADT7 were streaked out in complete 
drop-out medium (SCM) lacking tryptophan, leucine and histidine to test for histidine prototrophy. Two plasmids 
containing simian virus (SV) 40 large T antigen (LgT) in pGADT7 and p53 in pGBKT7 were co-transformed into 
AH109 and used as positive controls. His3 is a reporter gene in the system.
Gel filtration experiments. The dual expression plasmid was transformed into Rosetta II (DE3) (Invitrogen) 
E. coli strain, grown in Luria Bertani medium, and induced with 1 mM isopropyl-β -d-thiogalactopyranoside at an 
A600 ~ 0.8 for 2 hours. The bacterial pellets from 1L of growth media were resuspended in 30 mL of B-PER reagent 
(Thermo Scientific) and expressed protein purified from the lysis supernatant by Nickel affinity and gel filtration 
(Superdex 75 26/60, GE Healthcare) chromatography. The purified protein was concentrated and passed over the 
gel filtration column a second time before Western blot analysis.
Analysis of α-galactosidase reporter gene activity. α -Galactosidase reporter gene activity was meas-
ured following instructions provided by the manufacturer (Match-Maker two-hybrid System 3; Clontech). Briefly, 
AH109 clones co-transformed with indicated pairs of PACRG/pGADT7 and wild-type or mutant MEIG1/pGBKT7 
were cultured in SCM-Leu-Trp medium to optical density (OD)600 nm –1.0. One millilitre of culture from each 
inoculation (in triplicate) was centrifuged in a 1.5 ml centrifuge tube at 10,000 × g for 2 min, at 22 °C. The superna-
tants, which contained α -Galactosidase, were carefully transferred to fresh tubes on ice. Aliquots of 120 μ l of culture 
supernatant were mixed with 360 μ l of assay buffer [prepared by mixing two volumes of 0.5 mol/L sodium acetate 
pH 4.5 and 1 vol of 100 mmol/L of p-nitrophenyl α -D-galactopyranoside (PNP-α -Gal)]. The reaction mixes were 
incubated at 30 °C for 3 h before stopping the reaction with the addition of 520 μl of stop buffer (1 mol/L sodium 
carbonate). The OD410 of each reaction was recorded by a spectrophotometer using a reaction mix containing 
SCM-Leu-Trp medium in the place of culture supernatant as the blank. The activity was expressed either as arbi-
trary units or percentage of wild type gene (as a way to record interaction strength between PACRG and MEIG1 
mutants). Each assay was repeated five times and the average was reported.
Western blot analysis. Indicated bacteria or yeast protein lysates were heated to 95 °C for 10 min in 4× 
sample buffer, loaded onto 10% or 15% SDS-polyacrylamide gels, electrophoretically separated, and transferred 
to polyvinylidene difluoride membranes. The membranes were blocked and then incubated with antibodies 
against PACRG or MEIG1 overnight at 4 °C. Both antibodies were generated by our laboratory previously16. After 
washing, the blots were incubated with an anti-mouse or anti-rabbit immunoglobulin conjugated to horseradish 
peroxidase for 1 h at room temperature. PACRG or MEIG1 proteins were detected with the Super Signal Pico 
Chemiluminescent or Femto Maximum Sensitive system (Pierce). To compare expression level of target proteins, 
the films were scanned to JPEG files, and Images J software was used to calculate relative expression levels.
Statistical analysis. ANOVA test was used to determine statistical differences, the 2-tailed student’s t-test 
was used for comparison of frequencies. Significance is defined as P < 0.05.
Accession Numbers. The coordinates and NMR restraints for MEIG1 have been deposited in the Protein 
Data Bank (PDB ID: 2n2y); the NMR assignments have been deposited in the Biological Magnetic Resonance 
Bank (BMRB accession: 25627).
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